Pfizer Q3 net profit climbs 5%, operational revenue up at Rs 514 cr

The company had posted a net profit of Rs 131.94 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to BSE.

Pfizer
Shares of Pfizer Ltd were trading at Rs 4,350 per scrip on BSE, down 5.24 per cent. | Photo courtesy: Reuters
Press Trust of India New Delhi
1 min read Last Updated : Feb 14 2020 | 4:02 PM IST


Drug firm Pfizer Ltd on Friday reported a 5.39 per cent rise in net profit to Rs 139.06 crore for the quarter ended December 31, 2019.

The company had posted a net profit of Rs 131.94 crore for the corresponding period of the previous fiscal, Pfizer Ltd said in a filing to BSE.

Revenue from operations stood at Rs 538.18 crore for the quarter under consideration, as against Rs 513.79 crore in the same period a year ago. Shares of Pfizer Ltd were trading at Rs 4,350 per scrip on BSE, down 5.24 per cent.

 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Pfizer Q3Pfizer IndiaPfizer

First Published: Feb 14 2020 | 3:10 PM IST

Next Story